Valuation: Supergenics

Market Cap 29.11M 7.11M 6.21M 5.73M 5.28M 9.96M 684M 10.18M 68.5M 26.94M 335M 26.69M 26.1M 1.15B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 7.94M 6.93M 6.4M 5.9M 11.12M 764M 11.36M 76.49M 30.08M 374M 29.8M 29.15M 1.29B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 24/04/2019
Corporate Secretary - 02/06/2022
Director TitleAgeSince
Director/Board Member 60 24/04/2019
Director/Board Member 48 24/04/2019
Director/Board Member 46 28/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+13.64% 7.11M
-0.35%-3.77%+0.85%+2.53% 49.18B
-0.59%+0.84%+382.80%+591.61% 39.58B
+0.33%+3.07%+7.32%+62.42% 34.69B
-1.00%-1.86%+28.14%-10.02% 34.42B
+0.06%+0.34%+2.38%+34.47% 27.11B
-0.91%-1.97% - - 16.21B
-0.82%+0.59%+72.67%+116.01% 15.36B
+0.85%+1.99%+15.10%+17.90% 14.05B
-2.29%+0.37%+19.40%-32.62% 13.02B
Average +1.69%+0.02%+56.89%+88.44% 24.36B
Weighted average by Cap. -0.49%-0.18%+79.41%+122.69%

Financials

2024 2025
Net sales 5.32M 1.3M 1.14M 1.05M 966K 1.82M 125M 1.86M 12.52M 4.93M 61.28M 4.88M 4.77M 211M 5.63M 1.37M 1.2M 1.11M 1.02M 1.92M 132M 1.97M 13.24M 5.21M 64.78M 5.16M 5.04M 223M
Net income -7.28M -1.78M -1.55M -1.43M -1.32M -2.49M -171M -2.55M -17.13M -6.74M -83.84M -6.68M -6.53M -289M -3.37M -822K -718K -663K -611K -1.15M -79.13M -1.18M -7.92M -3.12M -38.76M -3.09M -3.02M -133M
Net Debt 4.48M 1.09M 955K 881K 813K 1.53M 105M 1.57M 10.54M 4.14M 51.56M 4.11M 4.02M 177M 3.39M 829K 724K 668K 616K 1.16M 79.8M 1.19M 7.99M 3.14M 39.08M 3.11M 3.04M 135M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock